Cantini, G., Fei, L., Canu, L., Lazzeri, E., Sottili, M., Francalanci, M., . . . Luconi, M. (2021). Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer Progression. MDPI AG.
Chicago Style (17th ed.) CitationCantini, Giulia, et al. Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer Progression. MDPI AG, 2021.
MLA (8th ed.) CitationCantini, Giulia, et al. Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer Progression. MDPI AG, 2021.
Warning: These citations may not always be 100% accurate.